GLP-1 agonists initially faced coverage challenges that have progressively improved
A rare human variant that disrupts GPR10 signalling causes weight gain in mice
This might reflect increased momentum and slightly higher levels of recent funding, perhaps providing us with more actionable medical knowledge on the condition to spur product development even without significant breakthrough in our foundational understanding
Use the units shown beside each input, and convert before you type if your notes use a different unit system
Among these compounds, erastin, sulfasalazine (SAS), RSL3, sorafenib, and FIN56 induce ferroptosis through the inhibition of the GSH/GPX4 pathway (201, 202)
Additionally, navitoclax is almost impenetrable to the blood brain barrier, thus, the current drugs are not able to reach the brain parenchyma (67)